[go: up one dir, main page]

AU2001283055A1 - Biological component comprising artificial membrane - Google Patents

Biological component comprising artificial membrane

Info

Publication number
AU2001283055A1
AU2001283055A1 AU2001283055A AU8305501A AU2001283055A1 AU 2001283055 A1 AU2001283055 A1 AU 2001283055A1 AU 2001283055 A AU2001283055 A AU 2001283055A AU 8305501 A AU8305501 A AU 8305501A AU 2001283055 A1 AU2001283055 A1 AU 2001283055A1
Authority
AU
Australia
Prior art keywords
biological component
artificial membrane
artificial
membrane
biological
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001283055A
Inventor
Elliot L Chaikof
Keith M. Faucher
June Feng
Hongbo Liu
Janine M. Orban
Xue Long Sun
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Emory University
Original Assignee
Emory University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Emory University filed Critical Emory University
Publication of AU2001283055A1 publication Critical patent/AU2001283055A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/655Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
    • C07F9/6552Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a six-membered ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/5021Organic macromolecular compounds
    • A61K9/5031Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poly(lactide-co-glycolide)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/32Proteins, polypeptides; Degradation products or derivatives thereof, e.g. albumin, collagen, fibrin, gelatin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14Macromolecular materials
    • A61L27/22Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/222Gelatin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14Macromolecular materials
    • A61L27/22Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/227Other specific proteins or polypeptides not covered by A61L27/222, A61L27/225 or A61L27/24
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14Macromolecular materials
    • A61L27/22Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/24Collagen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/507Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials for artificial blood vessels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L33/00Antithrombogenic treatment of surgical articles, e.g. sutures, catheters, prostheses, or of articles for the manipulation or conditioning of blood; Materials for such treatment
    • A61L33/0076Chemical modification of the substrate
    • A61L33/0082Chemical modification of the substrate by reacting with an organic compound other than heparin
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y30/00Nanotechnology for materials or surface science, e.g. nanocomposites
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • A61K9/1273Polymersomes; Liposomes with polymerisable or polymerised bilayer-forming substances
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F220/00Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride ester, amide, imide or nitrile thereof
    • C08F220/02Monocarboxylic acids having less than ten carbon atoms; Derivatives thereof
    • C08F220/10Esters
    • C08F220/26Esters containing oxygen in addition to the carboxy oxygen
    • C08F220/28Esters containing oxygen in addition to the carboxy oxygen containing no aromatic rings in the alcohol moiety
    • C08F220/281Esters containing oxygen in addition to the carboxy oxygen containing no aromatic rings in the alcohol moiety and containing only one oxygen, e.g. furfuryl (meth)acrylate or 2-methoxyethyl (meth)acrylate

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Nanotechnology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Materials Engineering (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Condensed Matter Physics & Semiconductors (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Physics & Mathematics (AREA)
  • Physics & Mathematics (AREA)
  • Vascular Medicine (AREA)
  • Microbiology (AREA)
  • Composite Materials (AREA)
  • Surgery (AREA)
  • Virology (AREA)
  • Medical Informatics (AREA)
  • Materials For Medical Uses (AREA)
AU2001283055A 2000-07-28 2001-07-30 Biological component comprising artificial membrane Abandoned AU2001283055A1 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US22165500P 2000-07-28 2000-07-28
US22161800P 2000-07-28 2000-07-28
US22182800P 2000-07-28 2000-07-28
US60/221,828 2000-07-28
US60/221,618 2000-07-28
US60/221,655 2000-07-28
PCT/US2001/024020 WO2002009647A2 (en) 2000-07-28 2001-07-30 Biological component comprising artificial membrane

Publications (1)

Publication Number Publication Date
AU2001283055A1 true AU2001283055A1 (en) 2002-02-13

Family

ID=27396969

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001283055A Abandoned AU2001283055A1 (en) 2000-07-28 2001-07-30 Biological component comprising artificial membrane

Country Status (5)

Country Link
US (1) US7713544B2 (en)
EP (1) EP1317253A4 (en)
JP (1) JP2004512062A (en)
AU (1) AU2001283055A1 (en)
WO (1) WO2002009647A2 (en)

Families Citing this family (89)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6346510B1 (en) 1995-10-23 2002-02-12 The Children's Medical Center Corporation Therapeutic antiangiogenic endostatin compositions
US6936298B2 (en) * 2000-04-13 2005-08-30 Emory University Antithrombogenic membrane mimetic compositions and methods
JP2004512062A (en) 2000-07-28 2004-04-22 エモリー ユニバーシテイ Biological components consisting of artificial membranes
WO2002055021A2 (en) 2001-01-12 2002-07-18 Univ Emory Glycopolymers and free radical polymerization methods
DE10121903A1 (en) * 2001-04-27 2002-10-31 Nimbus Biotechnologie Gmbh System for membrane permeation measurement
AU2003241531A1 (en) * 2002-05-21 2003-12-12 Emory University Multivalent polymers with chain-terminating binding groups
FR2855521B1 (en) * 2003-05-28 2005-08-05 Flamel Tech Sa POLYAMINOACIDES FUNCTIONALIZED BY AT LEAST ONE YDROPHOBIC GROUP AND THEIR PARTICULARLY THERAPEUTIC APPLICATIONS.
EP1684816B1 (en) 2003-10-28 2009-05-06 Medtronic, Inc. Methods of preparing crosslinked materials and bioprosthetic devices
EP1697543B1 (en) * 2003-11-21 2014-08-20 ANP Technologies, Inc. Asymmetrically branched polymer conjugates and microarray assays
CA2558661C (en) * 2004-02-06 2012-09-04 Georgia Tech Research Corporation Load bearing biocompatible device
EP1786485A4 (en) 2004-02-06 2012-05-30 Georgia Tech Res Inst Surface directed cellular attachment
US20080108515A1 (en) * 2004-02-10 2008-05-08 Gormley Niall A Arrayed polynucleotides
US7833978B2 (en) 2004-02-20 2010-11-16 Emory University Thrombomodulin derivatives and conjugates
US7354980B1 (en) 2004-03-12 2008-04-08 Key Medical Technologies, Inc. High refractive index polymers for ophthalmic applications
US7824672B2 (en) 2004-03-26 2010-11-02 Emory University Method for coating living cells
US8696564B2 (en) 2004-07-09 2014-04-15 Cardiac Pacemakers, Inc. Implantable sensor with biocompatible coating for controlling or inhibiting tissue growth
CA2576971A1 (en) * 2004-08-20 2006-03-02 Entremed, Inc. Compositions and methods comprising proteinase activated receptor antagonists
US7446157B2 (en) 2004-12-07 2008-11-04 Key Medical Technologies, Inc. Nanohybrid polymers for ophthalmic applications
JP5021183B2 (en) * 2005-05-20 2012-09-05 アークレイ株式会社 Protein immobilization membrane, immobilization method, and biosensor
DK2179780T5 (en) * 2005-05-20 2013-05-27 Aquaporin As Membrane for filtering water
JP5214857B2 (en) * 2005-06-20 2013-06-19 東レ株式会社 Porous substrate
EP1942957B1 (en) * 2005-10-27 2012-07-11 Coloplast A/S Biodegradable scaffold with ecm material
RU2450052C2 (en) * 2006-04-17 2012-05-10 Филадельфия Медикал Сайнтифик Сентер, Л.Л.К. Method for producing rabbit pancreatic beta cells and composition for stimulating natural insulin development in patient
US20090269313A1 (en) * 2006-07-19 2009-10-29 Diakine Therapeutics, Inc. Encapsulation system
US8105634B2 (en) 2006-08-15 2012-01-31 Anthrogenesis Corporation Umbilical cord biomaterial for medical use
WO2008033847A2 (en) 2006-09-11 2008-03-20 Emory University Modified protein polymers
WO2008060377A2 (en) 2006-10-04 2008-05-22 Anthrogenesis Corporation Placental or umbilical cord tissue compositions
EP2076279B1 (en) 2006-10-06 2014-08-27 Anthrogenesis Corporation Native (telopeptide) placental collagen compositions
US20080181928A1 (en) * 2006-12-22 2008-07-31 Miv Therapeutics, Inc. Coatings for implantable medical devices for liposome delivery
MX2009010000A (en) 2007-03-19 2010-03-17 Insuline Medical Ltd Drug delivery device.
US8622991B2 (en) 2007-03-19 2014-01-07 Insuline Medical Ltd. Method and device for drug delivery
US9220837B2 (en) 2007-03-19 2015-12-29 Insuline Medical Ltd. Method and device for drug delivery
GB0709259D0 (en) * 2007-05-14 2007-06-20 Ucl Business Plc Pores
EP2168196B1 (en) * 2007-06-29 2018-12-26 Universite Joseph Fourier - Grenoble 1 Biomimetic artificial membrane device
CN101918050A (en) * 2007-10-10 2010-12-15 Miv治疗有限公司 Lipid coatings for implantable medical devices
US8409133B2 (en) 2007-12-18 2013-04-02 Insuline Medical Ltd. Drug delivery device with sensor for closed-loop operation
US8795707B2 (en) * 2008-05-13 2014-08-05 Trustees Of Boston University Compliant composites for application of drug-eluting coatings to tissue surfaces
EP2300451A1 (en) 2008-06-02 2011-03-30 Cedars-Sinai Medical Center Nanometer-sized prodrugs of nsaids
EP3029467B1 (en) 2008-09-22 2020-01-08 University of Washington Msp nanopores and related methods
CA2743027C (en) 2008-11-07 2016-04-12 Insuline Medical Ltd. Device and method for drug delivery
GB0901857D0 (en) * 2009-02-05 2009-03-11 Nanoco Technologies Ltd Encapsulated nanoparticles
EP2295132B8 (en) * 2009-05-15 2017-03-15 Interface Biologics Inc. Antithrombogenic hollow fiber membranes, potting material and blood tubing
US20100316787A1 (en) * 2009-06-12 2010-12-16 Greatbatch Ltd. Biomimetic Coating Method
US9067179B2 (en) * 2009-12-31 2015-06-30 The Charles Stark Draper Laboratory, Inc. Microfluidic device facilitating gas exchange, and methods of use and manufacture thereof
CA2790672C (en) 2010-02-23 2018-05-29 University Of Washington Artificial mycolic acid membranes
JP5688791B2 (en) * 2010-05-11 2015-03-25 グレイトバッチ リミテッドGreatbatch Ltd. Surface modification for coating
EP2576026A1 (en) 2010-05-26 2013-04-10 The Charles Stark Draper Laboratory, Inc. Microfabricated artificial lung assist device, and methods of use and manufacture thereof
AU2012207206B2 (en) 2011-01-19 2015-10-08 President And Fellows Of Harvard College Slippery liquid-infused porous surfaces and biological applications thereof
US9353646B2 (en) 2011-01-19 2016-05-31 President And Fellows Of Harvard College Slippery surfaces with high pressure stability, optical transparency, and self-healing characteristics
EP2757964B1 (en) 2011-05-26 2016-05-04 Cartiva, Inc. Tapered joint implant and related tools
JP5807484B2 (en) * 2011-09-27 2015-11-10 日立化成株式会社 Thin film and manufacturing method thereof
IN2014CN04342A (en) 2011-12-05 2015-09-04 Draper Lab Charles S
US10350072B2 (en) 2012-05-24 2019-07-16 Cartiva, Inc. Tooling for creating tapered opening in tissue and related methods
US9963597B2 (en) 2012-07-12 2018-05-08 President And Fellows Of Harvard College Slippery self-lubricating polymer surfaces
WO2014012039A1 (en) 2012-07-13 2014-01-16 President And Fellows Of Harvard College Slippery liquid-infused porous surfaces having improved stability
CN104769049A (en) 2012-07-13 2015-07-08 哈佛学院 multifunctional resistant material
EP2941249A4 (en) * 2013-01-07 2016-09-28 Univ Maryland BIOCOMPATIBLE COATING COMPOSITIONS
GB201300465D0 (en) 2013-01-11 2013-02-27 Aquaporin As A hollow fiber module having tfc-aquaporin modified membranes
DK177696B1 (en) 2013-02-25 2014-03-17 Aquaporin As Systems for water extraction
WO2014209441A2 (en) 2013-03-13 2014-12-31 President And Fellows Of Harvard College Solidifiable composition for preparation of liquid-infused slippery surfaces and methods of applying
WO2014172663A1 (en) * 2013-04-19 2014-10-23 Cedars-Sinai Medical Center Nanometer-sized prodrugs of nsaids to treat traumatic brain injury
CN103405809B (en) * 2013-07-23 2015-01-21 东华大学 Method used for preparing microcarrier/polymer composite scaffold by electro-deposition
WO2015077401A1 (en) 2013-11-20 2015-05-28 Drexel University Compositions and methods for macrophage conversion
US11000285B2 (en) * 2013-12-17 2021-05-11 3Dt Holdings, Llc Luminal grafts and methods of making and using the same
DK3131920T3 (en) 2014-04-16 2021-11-22 Uab Res Found MSP NANOPORES AND USES THEREOF
JP2017513625A (en) 2014-04-23 2017-06-01 ザ チャールズ スターク ドレイパー ラボラトリー インク Blood oxygenator
WO2016004029A1 (en) * 2014-06-30 2016-01-07 The Arizona Board Of Regents On Behalf Of The University Of Arizona Systems and methods of preparing stabilized lipid assemblies
US9782727B2 (en) 2014-07-14 2017-10-10 International Business Machines Corporation Filtration membranes with functionalized star polymers
CN104177638B (en) * 2014-08-23 2016-10-12 吉林大学 Ordered porous polymer thin film, preparation method and the application in terms of capture and controlled sugar response uelralante
US9931598B2 (en) 2015-02-16 2018-04-03 International Business Machines Corporation Anti-fouling coatings with star polymers for filtration membranes
US10005042B2 (en) 2015-02-16 2018-06-26 International Business Machines Corporation Thin film composite forward osmosis membranes with performance enhancing layers
WO2016161026A1 (en) 2015-03-31 2016-10-06 Cartiva, Inc. Carpometacarpal (cmc) implants and methods
AU2016243659B2 (en) 2015-03-31 2020-04-23 Cartiva, Inc. Hydrogel implants with porous materials and methods
DE102016107480B4 (en) * 2016-04-22 2018-01-04 Christian-Albrechts-Universität Zu Kiel Layer with variable strength
CN109913401A (en) * 2016-09-14 2019-06-21 四川蓝光英诺生物科技股份有限公司 Artificial organ precursor and the method for preparing it
WO2018075663A1 (en) 2016-10-18 2018-04-26 Interface Biologics, Inc. Plasticized pvc admixtures with surface modifying macromolecules and articles made therefrom
US10961340B2 (en) 2017-07-14 2021-03-30 Fresenius Medical Care Holdings, Inc. Method for providing surface modifying composition with improved byproduct removal
WO2020077161A1 (en) 2018-10-11 2020-04-16 Freeflow Medical Devices Llc Packaging for medical devices coated with perfluorinated liquids or dispersions thereof
WO2020077160A1 (en) 2018-10-11 2020-04-16 Freeflow Medical Devices Llc Fluoropolymer based anti-thrombotic coatings
DE102018126842B4 (en) * 2018-10-26 2020-10-15 Carl Zeiss Meditec Ag Ophthalmic implant, method for producing an ophthalmic implant and use of a ligand for producing an ophthalmic implant
CN109925540B (en) * 2019-03-14 2021-04-16 西南交通大学 Method for mediating albumin to form protein layer on material surface, biomaterial and application thereof
CN110305253A (en) * 2019-06-30 2019-10-08 海南师范大学 Medical composite homogeneous scaffold of oxidized alginate/polyacrylamide interpenetrating network and preparation method thereof
AU2020352623A1 (en) 2019-09-27 2022-05-12 Isla Technologies, Inc. Bioartificial pancreas
CN110693836A (en) * 2019-10-21 2020-01-17 中国石油大学(华东) A kind of lipopeptide self-assembled ultra-small nanovesicles and preparation method thereof
CN111203115B (en) * 2020-01-07 2022-02-11 天津市第三中心医院 A kind of oxidized polysaccharide anticoagulation coating hemodialysis membrane material and preparation method thereof
CN111437442B (en) * 2020-05-08 2021-09-21 江南大学 Preparation method of degradable electrophoretic coating for magnesium-based medical implant surface
WO2022217024A1 (en) * 2021-04-09 2022-10-13 William Marsh Rice University Interfacial seeding of cells and particles on surfaces for diagnostics and therapeutics
CN115282341B (en) * 2022-06-27 2023-05-23 华南理工大学 Porous metal material with polypeptide bidirectional gradient distribution surface and preparation method and application thereof
CN115814159B (en) * 2023-02-23 2023-05-05 四川兴泰普乐医疗科技有限公司 Artificial crystal and preparation method thereof

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4485045A (en) 1981-07-06 1984-11-27 Research Corporation Synthetic phosphatidyl cholines useful in forming liposomes
US4522803A (en) 1983-02-04 1985-06-11 The Liposome Company, Inc. Stable plurilamellar vesicles, their preparation and use
US4560599A (en) 1984-02-13 1985-12-24 Marquette University Assembling multilayers of polymerizable surfactant on a surface of a solid material
US4885172A (en) * 1985-06-26 1989-12-05 The Liposome Company, Inc. Composition for targeting, storing and loading of liposomes
MX9203291A (en) 1985-06-26 1992-08-01 Liposome Co Inc LIPOSOMAS COUPLING METHOD.
US5755788A (en) 1987-02-19 1998-05-26 Rutgers, The State University Prosthesis and implants having liposomes bound thereto and methods of preparation
US4880883A (en) 1987-06-03 1989-11-14 Wisconsin Alumni Research Foundation Biocompatible polyurethanes modified with lower alkyl sulfonate and lower alkyl carboxylate
US4906465A (en) 1987-10-19 1990-03-06 Massachusetts Institute Of Technology Antithrombogenic devices containing polysiloxanes
US5288517A (en) 1988-08-26 1994-02-22 Canon Kabushiki Kaisha Method of forming planar membrane
FR2640955B1 (en) 1988-12-26 1991-11-29 Taillet Joseph
SE466259B (en) * 1990-05-31 1992-01-20 Arne Forsgren PROTEIN D - AN IGD BINDING PROTEIN FROM HAEMOPHILUS INFLUENZAE, AND THE USE OF THIS FOR ANALYSIS, VACCINES AND PURPOSE
JP3189052B2 (en) * 1990-06-27 2001-07-16 持田製薬株式会社 Polypeptide having anticoagulant activity
WO1993005825A1 (en) 1991-09-20 1993-04-01 Baxter International Inc. Processes for reducing the thrombogenicity of biomaterials
EP0597593A1 (en) 1992-10-30 1994-05-18 Medtronic, Inc. Thromboresistant articles
AU8012394A (en) 1993-10-01 1995-05-01 Emory University Self-expanding intraluminal composite prosthesis
US5932462A (en) 1995-01-10 1999-08-03 Shearwater Polymers, Inc. Multiarmed, monofunctional, polymer for coupling to molecules and surfaces
CN1196734A (en) * 1995-09-19 1998-10-21 生化学工业株式会社 Anti-inflammatory agent
US5911942A (en) 1995-11-02 1999-06-15 Tissue Engineering, Inc. Method for spinning and processing collagen fiber
US6071532A (en) 1996-10-15 2000-06-06 Emory University Synthesis of glycophospholipid and peptide-phospholipid conjugates and uses thereof
GB9704749D0 (en) * 1997-03-07 1997-04-23 Univ London Tissue Implant
US6071614A (en) * 1997-07-14 2000-06-06 3M Innovative Properties Company Microporous fluorinated silica agglomerate and method of preparing and using same
US6583251B1 (en) * 1997-09-08 2003-06-24 Emory University Modular cytomimetic biomaterials, transport studies, preparation and utilization thereof
US6214049B1 (en) * 1999-01-14 2001-04-10 Comfort Biomedical, Inc. Method and apparatus for augmentating osteointegration of prosthetic implant devices
WO2000000239A1 (en) 1998-06-30 2000-01-06 Emory University Modular cytomimetic biomaterials, transport studies, preparation and utilization thereof
US6936298B2 (en) * 2000-04-13 2005-08-30 Emory University Antithrombogenic membrane mimetic compositions and methods
AU2001255544A1 (en) 2000-04-20 2001-11-07 Emory University Native protein mimetic fibers, fiber networks and fabrics for medical use
JP2004512062A (en) 2000-07-28 2004-04-22 エモリー ユニバーシテイ Biological components consisting of artificial membranes
WO2002055021A2 (en) 2001-01-12 2002-07-18 Univ Emory Glycopolymers and free radical polymerization methods

Also Published As

Publication number Publication date
JP2004512062A (en) 2004-04-22
EP1317253A2 (en) 2003-06-11
EP1317253A4 (en) 2006-04-26
WO2002009647A2 (en) 2002-02-07
US7713544B2 (en) 2010-05-11
US20040063200A1 (en) 2004-04-01
WO2002009647A3 (en) 2002-07-25

Similar Documents

Publication Publication Date Title
AU2001283055A1 (en) Biological component comprising artificial membrane
AU2001273164A1 (en) Membrane associated protein zupari
AU2001286207A1 (en) Porous membrane
AU2001233227A1 (en) Artificial heart valve
AU2001281758A1 (en) Biocompatible materials
AU9517301A (en) Implant
AU2001231447A1 (en) Artificial tree
AU7862200A (en) Flip-wing tissue retainer
AU2001238359A1 (en) Membranes
AU2001276692A1 (en) Modified hollow-fiber membrane
AU2023301A (en) Improved prosthesis
AU2001263841A1 (en) Implant
AU2001256020A1 (en) Biological sounds monitor
AU2001259702A1 (en) Tissue regrafting
AU2002360067A1 (en) Permeable membrane
AU2203901A (en) Microporous membrane
AU2002358214A1 (en) Membrane
AU2002227925A1 (en) Human beta-defensin-3
AU4081900A (en) Porous membrane
AUPR069500A0 (en) Tissue modification
AU2001242738A1 (en) Novel artificial organ system
AU2001228324A1 (en) Biological microsensor
AU2001260116A1 (en) Human dcc-like proteins
AU2002211097A1 (en) Artificial manes
AU2002246344A1 (en) Artificial dialysis